EKSO 240816 2.50C (EKSO240816C2500) Stock Options, News & Quotes

0.05
0.000.00%

15min DelayClose Aug 14 12:40 ET

0.00High0.00Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Qianmeng

Jul 29 10:00

Let’s walk

$Ekso Bionics (EKSO.US)$earning is good enough. Might average down a little bit if there is dip. See you at 3 dollar.

Stock Region

Mar 5 13:32

Leading Exoskeleton Solutions Company Reports Record $18.3M Revenue

Record Annual Revenue of $18.3 Million for Ekso Bionics: A Deep Dive into the Company's Success.
Ekso Bionics Holdings, Inc. ($EKSO), a leading developer of exoskeleton solutions that amplify human potential, has recently reported a record annual revenue of $18.3 million. This remarkable achievement highlights the company's successful business strategies and its ongoing commitment to innovation in the realm of robotic exoskeleton...

Qianmeng

Jan 11 09:21

Beat to break legs

$Ekso Bionics (EKSO.US)$ $ReWalk Robotics (RWLK.US)$ EKSO had some financing at 1.55 is not a bad. On other hand, that means revenue from medicare probably won’t be enough to make company profitable in short term.
Be careful.

Trytosaveabit

Jan 11 07:08

Crash coming??? Hehehe

$Ekso Bionics (EKSO.US)$Moomoo 24/7· 2 mins ago
Ekso Bionics Entered Into A Securities Purchase Agreement With Certain Institutional Investors For 2.9M Shares At $1.55/Share, With Gross Proceeds Of Approximately $4.6M

Moomoo AI

Dec 12, 2023 08:01

Ekso Bionics considers the CMS approval to positively impact SCI patients' health outcomes by increasing affordability of Ekso Indego Personal. This decision is expected to expand the patient population, potentially boosting product sales.

Press Release: Ekso Bionics Receives CMS Coding Approval for Ekso Indego Personal